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Abstract 
Background: The present study was conducted to compare the effect on intubating conditions and haemodynamic 
changes using Vecuronium and Rocuronium bromide for laryngoscopy. Materials & Methods: The present study 
was conducted on 40 ASA grade I and grade II patients which were divided into 2 groups of 20 each. Group I 
patients received Inj. Rocuronium and group II patients received Inj. Vecuronium. Time in seconds from injection of 
study drug till TOF score 0 (onset time) and duration of action were measured by intermittently noting response to 
TOF. Parameters such as onset of action, intubating conditions, heart rate and train of four monitoring was recorded. 
Results: The mean train of four monitoring was 62.4 seconds in group I and 138.2 seconds in group II, duration of 
action was 42.6 minutes in group I and 46.4 minutes in group II. The difference was significant (P< 0.05). Intra-
operative laryngoscopy status was easy in all patients in both groups. The mean heart rate (beats/min) at baseline in 
group I was 82.4 and in group II was 84.2, after intubation in group I was 91.4 and I group II was 94.6 and after 10 
minutes in group I was 80.6 and in group II was 83.1. The difference was significant (P< 0.05). Conclusion: 
Authors found that both Rocuronium and Vecuronium were found to be equally effective. There was no difference 
in intubating conditions and haemodynamic response between both agents.  
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Introduction 
 
 
The introduction of neuromuscular blocking drugs, in 
anaesthesia practice, the incontrovertible advantages of 
intubation in the safe maintenance of airway have 
changed the indication of intubation from specific need 
to almost a routine use in general anaesthesia practice. 
Thus, the use of muscle relaxant has become an 
important aspect of modern anaesthesia[1].The use of 
neuromuscular blocking agents (NMBA) to facilitate 
tracheal intubation is a widely accepted procedure. 
Direct laryngoscopy stimulates the oropharynx and 
activates oropharyngeal reflexes.  
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However, the use of NMBA will inhibit muscular 
contractions and improve conditions for tracheal 
intubation. Due to adverse effects the use of NMBA 
may be undesirable. Both depolarising and non-
depolarising NMBA may have side effect as 
anaphylaxis, cardiovascular effects related to histamine 
release or sympathomimetic properties, bronchospasm 
and prolonged paralysis[2].The unwanted side-effects 
includes: muscle fasciculations, post-operative 
myalgia, hyperkalemia, increased intraocular, 
intracranial pressures, and cardiovascular effects which 
include bradyarrhythmias and Asystole. The search for 
better drugs to meet the properties of an ideal 
neuromuscular blocking agent, led to the development 
of new non- depolarizing neuromuscular blocking 
drugs[3]. Vecuronium and Atracurium are free from 
various side effects encountered with Suxamethonium. 
However even after intubating doses, onset time is 
relatively slow as compared with Suxamethonium that 
of for rapid tracheal intubation. The use of high initial 
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bolus dose of either Atracurium or Vecuronium 
shortens the onset time, but at the expense of a 
prolonged duration of action, which may be 
undesirable in certain situations[4]. The present study 
was conducted to compare the effect on intubating 
conditions and haemodynamic changes using 
Vecuronium and Rocuronium bromide for 
laryngoscopy. 
 
Materials & Methods 
The present study was conducted in the Department of 
Anesthesiology. It comprised of 40 ASA grade I and 
grade II patients from different surgical specialties. The 
study was approved form ethical committee and 
consent of all patients was taken. Data such as name, 
age, gender etc. was recorded. Patients were divided 
into 2 groups of 20 each. Group I patients received Inj. 
Rocuronium and group II patients received Inj. 
Vecuronium. Time in seconds from injection of study 
drug till TOF score 0 (onset time) and duration of 
action were measured by intermittently noting response 
to TOF. All were premedicated and induced with Inj. 
Fentanyl and Inj. Propofol. 
Parameters such as onset of action, intubating 
conditions, heart rate and train of four monitoring was 
recorded. Results were tabulated and subjected to 
statistical analysis. P value less than 0.05 was 
considered significant. 
 
Results 
Table 1: Distribution of patients 
Groups Group I Group II 
Agent Inj. Rocuronium Inj. Vecuronium. 
Number 20 20 
 
Table I shows that group I patients received Inj. Rocuronium and group II patients received Inj. Vecuronium. Each 
group had 30 patients. 
Table 2:Comparison of parameters 
Parameters Group I (mean) Group II (mean) P value 
Train of four monitoring (secs) 62.4 138.2 0.01 
Duration of action (mins) 42.6 46.4 0.02 
Intra-operative laryngoscopy status 
Easy 20 20 1 
Difficult 0 0 
 
Table II shows that mean train of four monitoring was 
62.4 seconds in group I and 138.2 seconds in group II, 
duration of action was 42.6 minutes in group I and 46.4 
minutes in group II. The difference was significant (P< 
0.05). Intra-operative laryngoscopy status was easy in 
all patients in both groups. The difference was non- 
significant (P> 0.05). 
 
Discussion 
 
Difficulties with tracheal intubation (DTI) by direct 
laryngoscopy can cause serious soft tissue damage and 
DTI may be the principal causes of hypoxemic death 
and brain damage in relation to anaesthesia. A review 
identified difficult airway management as the main 
cause of death and severe morbidity related to 
anaesthesia. The risk of DTI may be reduced by 
choosing an induction strategy including, or avoiding, 
NMBA for facilitating tracheal intubation[5].Before 
discovery of muscle relaxant, intubation was difficult 
as anaesthesia was in primitive stage. With subsequent 
discovery of drugs like Succinylcholine, Gallalium, 
Curare derivatives intubating patient made easy. But 
they were associated with many side effects. Like 
Pancuronium is long acting muscle relaxant but have 
Vagolytic effect. Atracurium is short acting muscle 
relaxant but it has histamine releasing property though 
these muscle relaxants do provide good intubating 
conditions[6]. Prolonged apnea may be encountered in 
individuals with atypical Pseudocholinesterase. It may 
also induce malignant hyperthermia and 
Myoglobinuria, a grave situation in susceptible 
patients.  Thus, it falls short of an ideal muscle relaxant 
due to its potentially hazardous side effects, in spite of 
having the advantages of rapid action and quick 
recovery[7,8]. The present study was conducted to 
compare the effect on intubating conditions and 
haemodynamic changes using Vecuronium and 
Rocuronium bromide for laryngoscopy.In this study, 
group I patients received Inj. Rocuronium and group II 
patients received Inj. Vecuronium. Each group had 30 
patients. Pawar et al[9] compared the effect on 
intubating conditions and haemodynamic changes 
using Vecuronium and Rocuronium bromide for 
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laryngoscopy in 60 patients. All patients were 
randomly allocated into two groups of 30 each. All 
were premedicated and induced with Inj. Fentanyl and 
Inj. Propofol. After induction tracheal intubation was 
facilitated by giving either Inj. Rocuronium 0.6 mg/kg 
or Inj. Vecuronium 0.1 mg/kg to patients of Group A 
and Group B respectively. Anaesthesia was maintained 
on N2O (66.6%) and O2 (33.3%) mixture Analgesics, 
and either Vecuronium or Rocuronium as muscle 
relaxant with Sevoflurane. We found that mean train of 
four monitoring was 62.4 seconds in group I and 138.2 
seconds in group II, duration of action was 42.6 
minutes in group I and 46.4 minutes in group II. The 
difference was significant (P< 0.05). Intra-operative 
laryngoscopy status was easy in all patients in both 
groups. Robertson EN et al[10] reported that 
Rocuronium provide clinically acceptable intubating 
conditions in shorter time with least side effects as 
compared to succinylcholine and vecuronium.We 
found that mean heart rate (beats/min) at baseline in 
group I was 82.4 and in group II was 84.2, after 
intubation in group I was 91.4 and I group II was 94.6 
and after 10 minutes in group I was 80.6 and in group 
II was 83.1. Neeraja Bharti et al[11] demonstrated that 
the rate of development of neuromuscular block and 
hence the onset of action was faster with Rocuromium 
than Vecuromium. Lin et al[12]  observed that clinical 
durations of action were 44.2 +/- 13.2 min in 
Rocuronium group and 42.5 +/- 9.1 min in Vecuronium 
group respectively. W.M. Schramm et al concluded 
that there was no significant change in the mean 
arterial pressure after treatment with Rocuronium (0.6 
mg/kg) and Vecuronium (0.1 mg/kg). 
 
Conclusion 
 
Authors found that both Rocuronium and Vecuronium 
were found to be equally effective. There was no 
difference in intubating conditions and haemodynamic 
response between both agents.  
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